Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0789
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Successful Local Regional Therapy With Topotecan of Intraperitoneally Growing Human Ovarian Carcinoma Xenografts

British Journal of Cancer
Cancer ResearchOncology
1995English

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors

PLoS ONE
Multidisciplinary
2012English

Topotecan in Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

A Novel Synthetic Dihydroindeno[1,2-B] Indole Derivative (LS-2-3j) Reverses ABCB1- And ABCG2-Mediated Multidrug Resistance in Cancer Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

Six1 Overexpression in Ovarian Carcinoma Causes Resistance to TRAIL-Mediated Apoptosis and Is Associated With Poor Survival

Cancer Research
Cancer ResearchOncology
2007English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Immuno-Pet Evaluation of in Vivo Therapeutic Resistance in Renal Cell Carcinoma Patient-Derived Xenografts

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Induced and Inherent Resistance to Alkylating Agents in Human Small-Cell Bronchial Carcinoma Xenografts

British Journal of Cancer
Cancer ResearchOncology
1984English

Phase II Trial of Lapatinib and Topotecan (LapTop) in Patients With Platinum-Refractory/Resistant Ovarian and Primary Peritoneal Carcinoma

Gynecologic Oncology
GynecologyOncologyObstetrics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy